Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin in combination therapy for ovarian cancer.
ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Neijt JP, George M, Guastalla JP, Veenhof CH, Rotmensz N, Dalesio O, Vermorken JB. ten Bokkel Huinink WW, et al. Among authors: guastalla jp. Cancer Treat Rev. 1988 Jun;15 Suppl B:9-15. doi: 10.1016/0305-7372(88)90030-8. Cancer Treat Rev. 1988. PMID: 3135934 Clinical Trial.
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.
Creemers GJ, Bolis G, Gore M, Scarfone G, Lacave AJ, Guastalla JP, Despax R, Favalli G, Kreinberg R, Van Belle S, Hudson I, Verweij J, Ten Bokkel Huinink WW. Creemers GJ, et al. Among authors: guastalla jp. J Clin Oncol. 1996 Dec;14(12):3056-61. doi: 10.1200/JCO.1996.14.12.3056. J Clin Oncol. 1996. PMID: 8955650 Clinical Trial.
Phase I study of gemcitabine using a once every 2 weeks schedule.
Vermorken JB, Guastalla JP, Hatty SR, Seitz DE, Tanis B, McDaniels C, Clavel MD. Vermorken JB, et al. Among authors: guastalla jp. Br J Cancer. 1997;76(11):1489-93. doi: 10.1038/bjc.1997.583. Br J Cancer. 1997. PMID: 9400947 Free PMC article. Clinical Trial.
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes.
Fumoleau P, Chauvin F, Namer M, Bugat R, Tubiana-Hulin M, Guastalla JP, Delozier T, Kerbrat P, Devaux Y, Bonneterre J, Filleul A, Clavel M. Fumoleau P, et al. Among authors: guastalla jp. J Clin Oncol. 2001 Feb 1;19(3):612-20. doi: 10.1200/JCO.2001.19.3.612. J Clin Oncol. 2001. PMID: 11157010 Clinical Trial.
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923).
van Rijswijk RE, Vermorken JB, Reed N, Favalli G, Mendiola C, Zanaboni F, Mangili G, Vergote I, Guastalla JP, ten Bokkel Huinink WW, Lacave AJ, Bonnefoi H, Tumulo S, Rietbroek R, Teodorovic I, Coens C, Pecorelli S. van Rijswijk RE, et al. Among authors: guastalla jp. Eur J Cancer. 2003 Mar;39(4):481-7. doi: 10.1016/s0959-8049(02)00740-2. Eur J Cancer. 2003. PMID: 12751379 Clinical Trial.
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group.
Guastalla JP, Vermorken JB, Wils JA, George M, Scotto V, Nooij M, ten Bokkel Huinnink WW, Dalesio O, Renard J. Guastalla JP, et al. Eur J Cancer. 1994;30A(1):45-9. doi: 10.1016/s0959-8049(05)80017-6. Eur J Cancer. 1994. PMID: 8142163 Clinical Trial.
166 results